Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0

Size: px
Start display at page:

Download "Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0"

Transcription

1 Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0 SIEMENS AG Industry Sector I IA VSS Pharma D Karlsruhe, Germany pharma@siemens.com November 2013 SIEMENS AG

2 Table of Contents Introduction The Requirements in Short Meeting the Requirements with COMOS Life Cycle and Validation of Computerized Systems Suppliers and Service Providers Data Integrity Centrally managed data Managing of documents with COMOS PQM (Project Quality Management) Workflow suport Backup & Restore Audit Trail, Change Control Support Working layer Audit Trail / History Monitoring Revisioning / Versioning of documents System Access, Identification Codes and Passwords Electronic Signature Evaluation List for COMOS Life Cycle and Validation of Computerized Systems Suppliers and Service Providers Data Integrity Audit Trail, Change Control Support System Access, Identification Codes and Passwords Electronic Signature Open Systems Appendix A references SIEMENS AG 2013

3 Introduction Introduction Life science industries are increasingly basing key decisions on regulated records that are often being generated, processed and kept electronically. Further than that reviews and approval of such data are also being provided electronically. Thus the appropriate management of electronic records and electronic signatures become an important topic for the life science industries. Accordingly regulatory bodies defined criteria under which electronic records and electronic signatures will be considered being as reliable and as trustworthy as paper records and handwritten signatures executed on paper. These requirements have been set forth by the US FDA in 21 CFR Part 11 1 (in short: Part 11) and by the European Commission in Annex 11 to chapter 4 of the EU GMP Guideline 2 (in short: Annex 11). Since requirements on electronic records and electronic signatures are always tied to a computerized system being in a validated state, both regulations also include stipulations on validation and life-cycle of the computerized system. Application of Part 11 and Annex 11 (or their corresponding implementation in national legislation) is mandatory for the use of electronic records and electronic signatures. However, these regulations are only valid within their defined scope. The scope of both regulations is defined by the regional market the finished pharmaceutical is distributed to, and by whether or not the computerized systems and electronic records are used as a part of GMP-regulated activities (see Part and Annex 11 Principle 2 ). Supplemental to the regulations a number of guidance documents, good practice guides and interpretations have been published in recent years to support the implementation of the regulations. Some of them are being referred to within this document.. To help its clients, Siemens as supplier of COMOS evaluated version 10.0 of the system with regard to these requirements and published its results in this Compliance Response. Due to its level of detail, this analysis is based on the regulations and guidelines mentioned above. COMOS V10.0 fully meets the functional requirements for the use of electronic records and electronic signatures. Operation in conformity with the regulations is ensured in conjunction with organizational measures and procedural controls to be established by the client (the regulated company). Such guidelines are mentioned in section 3 of this document. This document is divided into three parts: chapter 1 provides a brief description of the requirement clusters, while chapter 2 introduces the functionality of COMOS V10.0 as means to meet those requirements. Chapter 3 contains a detailed system assessment on the basis of the single requirements of the according regulations CFR Part 11 Electronic Records; Electronic Signatures, US FDA, March 20 th 1997 (revised as of April 1st, 2013) 2 Volume 4 Good Manufacturing Practice Medicinal Products for Human and Veterinary Use / Annex 11: Computerised Systems, European Commission / EudraLex, June 30 th 2011 SIEMENS AG

4 1 The Requirements in Short Annex 11 and Part 11 take into account that the risk of manipulation, misinterpretation and changes without leaving a visible trace is higher with electronic records and electronic signatures, than with conventional paper records and handwritten signatures. Furthermore the means to restrict access to electronic records to authorized individuals are very different to those required to restrict access to paper records. Additional measures are required for such reasons. The terms electronic record / electronic document mean any combination of text, graphics, data, audio, pictorial or other information representation in digital form, that is created, modified, maintained, archived, retrieved or distributed by a computer system. The term electronic signature means a computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be the legally binding equivalent of the individual s handwritten signature. Since electronic signatures are also considered being electronic records by themselves, all requirements on electronic records are applied to electronic signatures too. The following table provides an overview of the requirements from both regulations. Requirement Life Cycle and Validation of the Computerized System Suppliers and Service Providers Data Integrity Audit Trail, Change Control Support System Access, Identification Codes and Passwords Description Computerized systems used as a part of GMP-related activities must be validated. The validation process should be defined using a risk-based approach. It should cover all relevant steps of the lifecycle and must provide appropriate documented evidence. The systems functionality should be traceable throughout the lifecycle by being documented in specifications or a system description. A formal change control procedure as well as an incident management should be established. Periodic evaluation should confirm that the validated state of the system is being maintained. Since competency and reliability of suppliers and service providers are considered as key factors, the supplier assessment should be chosen using a risk-based approach. Formal agreements should exist between the regulated user and these 3 rd parties, including clear responsibilities of the 3 rd party. Under the requirements of both regulations electronic records and electronic signatures must be as reliable and trustworthy as paper records. The system must provide the ability to discern altered records. Built-in checks for the correct and secure handling of data should be provided for manually entered data as well as for data being electronically exchanged with other systems. The system s ability to generate accurate and complete copies is essential for the use of the electronic records for regulated purposes. Beside recording changes to the system itself as mentioned above, both regulations require that changes on GMP-relevant data are being recorded. Such audit trail must include information on the change (before / after data), the identity of the operator, a time stamp, as well as the reason for the change. Access to the system must be limited to authorized individuals. Attention should be paid to password security. Changes on the configuration of user access management should be recorded. Periodic reviews should ensure the validity of identification codes. Procedures should exist for recalling access rights if a person leaves and for loss management. Special consideration should be given to the use of devices that bear or generate identification code or password information. 4 SIEMENS AG 2013

5 The Requirements in Short Requirement Electronic Signature Open Systems Description Regulations consider electronic signatures being legally binding and generally equivalent to handwritten signatures executed on paper. Beyond requirements on identification codes and passwords as stated above, electronic signatures must be unique to an individual. They must be linked to their respective electronic record and not be copied or otherwise being altered. Open systems might require additional controls to ensure data integrity and confidentiality. SIEMENS AG

6 2 Meeting the Requirements with COMOS The following sections provide an overview how the regulatory requirements mentioned in section 1 can be fulfilled while working with COMOS. Nonetheless detailed recommendations and instructions are described in the COMOS documentation as mentioned and referred to in the following overview. 2.1 Life Cycle and Validation of Computerized Systems Although Annex 11 in 1992 and Part 11 in 1997 underlined that a computerized systems should be subject to validation, it was not until the 2011 revision of Annex 11, that a comprehensive set of criteria for the validation of the system and its life-cycle had been introduced. Nonetheless the requirements to validate a computerized system and to keep it in a validated state had long been a part of regulations other than Part 11 and Annex 11. Which had been the motivation for the ISPE 3 to publish practical guidance like the Baseline Guide 4, the GAMP 5 5 guide as well as the GAMP Good Practice Guides. Thus the systems life-cycle as well as the approach to validation should be defined considering the guidance from the GAMP 5 guide. The guide also includes a number of appendices for life-cycle management, system development and operation of computerized systems. Since most pharmaceutical companies already have a validation methodology for computerized systems as a part of their process landscape, it is preferable to setup the systems life-cycle and validation according to these. 2.2 Suppliers and Service Providers Especially Annex 11 introduces a number of requirements for the selection of suppliers and risk-based supplier assessments in its sections three (Suppliers and Service Providers) and four (Project Phase). These requirements are also congruent with the recommendations of GAMP 5 Annex 11. Siemens as the manufacturer of COMOS is operating its business based on its Quality Management System and its Product LifeCycle Management Process. 2.3 Data Integrity Centrally managed data The integrated COMOS software concept is based on object orientation. Components are described holistically and displayed graphically in their true-to-life representation. The graphical and data related description, which includes all data associated with the component, forms a single unit within the database The complete plant information is stored in a central database. As a result, all disciplines and departments involved in the engineering and operating phases always access the same data for a given object. Changes to objects or documents are thus available to every user directly within the relevant engineering document. Related data sheets, lists, and other documents are linked to the 3 ISPE; International Society of Pharmaceutical Engineers, 4 Baseline Pharmaceutical Engineering Guides for New and Renovated Facilities, 5 GAMP 5 A Risk-Based Approach to Compliant GxP Computerized Systems, ISPE, SIEMENS AG 2013

7 Meeting the Requirements with COMOS corresponding objects. Every change of an object is checked against in build validation rules, before the change is performed. Figure 1: Object orientation in COMOS COMOS manage data centrally in the network. Thus, the PCs of users are "clients" and access a common "server". If multiple clients in networks work with a common stock of data, it is necessary to ensure that all information is constantly updated on all stations. This necessary constant data exchange and the corresponding coordination is ensured in COMOS by the Cache Validation Service (CVS). More information about the CVS can be found in Managing of documents with COMOS PQM (Project Quality Management) The operation of a plant requires numerous documents which are very important for information brokering, tracking and quality control. Apart from the documents created by COMOS, you also need certain external documents, such as device specifications from the manufacturer, communication with customers, old inventory documents of other software suppliers, etc. There is no need, however, to fully integrate these documents, as they do not have to be edited in the COMOS applications. COMOS PQM enables the complete mapping of technical plant documentation due to simple management of external documents. Nevertheless, structured and simple management of the documents is required in order to be able to access external documents quickly. 6 Infrastructure planning, Operating Manual, 09/2011, A5E SIEMENS AG

8 COMOS PQM (Project Quality Management) enables complete technical mapping of the plant in one database. External documents including metadata are attached to the objects on the basis of object orientation. Mandatory Metadata are defined per document type and their completeness is checked before a document can be checked in. Figure 2: Metadata for a document object in COMOS PQM 7 COMOS PQM differentiates plant documentation from project documentation. Plant documentation includes the latest documents and describes the as-built status of the plant. Project-specific changes can be made without changing the plant documentation. Figure 3: Plant and project documentation This is accomplished using working layers with different views of the plant documentation. In this way, you can test and optimize projects in a safe environment. Once engineering is complete and the changes accepted, the project-specific changes can be integrated into the plant documentation. Next to that it is possible to archive the changes inside the database with history tracking and locking the working layer against further changes. 7 PQM, Operating Manual, 08/2011, A5E SIEMENS AG 2013

9 Meeting the Requirements with COMOS Workflow Support Pre-configured processes can be defined in COMOS workflows based on the integrated Windows Workflow Foundation technology. Figure 4: COMOS workflows The COMOS workflow consists of individual tasks. The single tasks are connected with each other with the Workflow Designer by means of a simple flow diagram. Specific User and/or user groups can be assigned to each task to ensure the correct sequence of working steps as described in the Workflow Operating Manual Backup & Restore COMOS data consists of two components: The actual database in which information regarding the COMOS objects and all administrative information is stored. An associated document directory in which the report files are stored. To ensure data consistency, the database and the document directory need to be back up at the same time. Depending upon which architecture is implemented, either standard platform functionality or software can be used to backup and retrieve electronic records. The implementation of the archiving tools and software is varied per installation to optimize the archiving of records. Optional additional integrity can be achieved through the use of standard technologies such as RAID. The end user is responsible for maintaining the records throughout the retention period. The Maintenance Operation Manual 9 provides further guidance. 8 Workflow, Operating Manual, 02/2011, A5E Maintenance, Operating Manual, 09/2011, A5E SIEMENS AG

10 2.4 Audit Trail, Change Control Support Working layer Simultaneous engineering is the simultaneous implementation of originally consecutive work steps and plays a decisive role in efficient plant engineering. With the innovative working layer technology, COMOS enables optimum implementation of simultaneous engineering. Working layers are different views of the same plant data. Thus, engineering data and plant objects can be processed by several users in parallel, without changing the original database of the plant. The implemented work steps can then easily be consolidated with the original plant data and released in the as built status of the plant. Furthermore, the working layer technology is very well-suited for running through various scenarios in a secure environment. For example, different planning statuses can be extensively tested and optimized. Multiple working layers can be created side-by-side and compared. Figure 5: COMOS Working Layer technology Working layers are overlapping views of an engineering project in which work can be performed in parallel without manipulating the common database. They can be used to version control projects (unlimited number of versions) and allow access to deeper-lying working layers as well as creation of objects in the working layer s own layer. Thus, changes can first be tested and then if necessary rejected and deleted. See the Basic Operation Operating Manual 10 for further details. 10 Basic Operation, Operating Manual, 08/2011, A5E SIEMENS AG 2013

11 Meeting the Requirements with COMOS Audit Trail / History Monitoring The Audit trail/history monitoring feature provides an overview of the changes made within the working layers, when they are released into the released area. The aim of the project history is to track the project-based release of all objects. History entries permanently store the various editing states of the data, but only if it concerns validated data. According to the working layer model in COMOS, there are therefore only history entries for Level 0 (zero), this being the released area. The released area includes the validated data, while the subsequent working layers can only include data that is still incomplete or has not been checked yet. Figure 6: Create a history entry When a working layer is released into the released area, a backup copy of the objects is created in advance. The backup copy contains all own data. All data that only shines through are not saved in the backup copy. This applies both to inherited attribute values and to information that was applied from references. A time stamp is automatically written to the history entry as well Figure 7: Object history An overview of all history entries can be listed in the "Working layer/history management" context menu. Also s See the Basic Operation Operating Manual 10 for further details. SIEMENS AG

12 2.4.3 Revisioning / Versioning of documents COMOS native (Internal) and third party (external) documents can be easily revised within COMOS. Different users can review a document which is then released in a final step. The released document is then available as Adobe PDF and can no longer be edited. The history such as author, review steps, person responsible for release etc. is attached to the respective object in the form of metadata The software provides the option to implement controlled individual or bulk revisions of centrally collected and stored data. Various workflows are available for this purpose, which can be preconfigured in the system for the specific document type. These workflows ensure an efficient, controlled project flow. In COMOS the revision information is displayed form of a table. Figure 8: Revision Table The revision table contains the information which revision step was performed by whom and when 11. All external documents are automatically archived in COMOS. Archiving takes place with versioning: COMOS archives automatically a version of the document, when it is checked in for the first time. Before a document can be edited, it needs to be checked out. During the checkout process a completely new version of the document is created. All previous versions of the document are kept and can be accessed at any time. No data is lost and you can always trace who made which changes to the document at a specific time. If necessary, old versions can also be recalled and declared to be the current version once again. Figure 9: Document version history A detailed description of the COMOS document version management can be found in the PQM Operating Manual Revisions, Operating Manual, 09/2011, A5E SIEMENS AG 2013

13 Meeting the Requirements with COMOS 2.5 System Access, Identification Codes and Passwords During the COMOS start users identify themselves with their windows system user credentials. Figure 10: COMOS logon Individual users and their assignment to Windows user groups are defined in the Windows user administration. When logging into the database, each user is automatically created as a user in the COMOS user management with his system login name. Thereby the following access security requirements are fulfilled: Central user management (setup, deactivation, blocking, unblocking, assignment to user groups) by the administrator Unique combination of a user identification (user ID) and password Definition of access rights for groups and users Access and authorization levels depending on specific plant areas Password aging: The user is forced to change his/her password on expiration of a configurable time; the password can be reused only after n generations. The system can prompt the user to define a new password at initial logon (initial password). The user is automatically blocked after a configurable number of failed logon attempts and can only be unblocked by the administrator. Automatic logoff (auto-logout) after a configurable idle time of the keyboard and mouse Log functions for actions related to access security, such as logon, manual and automatic logoff, input of incorrect user ID or password, user blocked after several attempts to enter an incorrect password, and password change by user. Initially a COMOS user has no rights in the database until an administrator grants it. All COMOS user rights are based on the individual rights as well as the rights of those COMOS user groups of which the user is a member of. Both the individual rights and the rights of the COMOS user group can derive from the user management as well as from the object management. 12 PQM, Operating Manual, 08/2011, A5E SIEMENS AG

14 Apart from the meta-rights, which are not related to a specific project, rights always only take effect within a project. It does not matter if this concerns an object right, a function right or the assignment of working areas; the assigned rights are valid for a specific project only Electronic Signature Documents can be signed with a digital signature using the esign technology. esign enables the user to carry out a revision step and link it to your electronic signature. The signature is protected by a personal password. COMOS uses PFX certificates to sign a document digitally. In case of signing the document COMOS verifies if the certificate is a valid PFX file and if the entered password matches the password saved in the PFX file. Figure 11: COMOS esign If the verification is successful, the data relevant for the electronic signature is saved in the database. With the help of the estamp functionality the electronic signature is visualized on the PDFfile. Figure 12: estamp on P&ID Modifications to PDF documents with digital signature are monitored by COMOS and the validity or invalidity of the contents of documents is indicated with estamp technology Rights, Operating Manual, 09/2011, A5E Revisions, Operating Manual, 09/2011, A5E SIEMENS AG 2013

15 Evaluation List for COMOS 3 Evaluation List for COMOS The following list of requirements includes all regulatory requirements from 21 CFR Part 11 as well as from Annex 11. All requirements are structured in the same way introduced in part 1 of this Compliance Response. The enlisted requirements fully considers both regulations, regardless if technological or procedural controls or a combination of both are needed to fully Part 11 and Annex 11 The answers include if applicable how the requirement is handled during the development of the product and which measures should be implemented during customization and operation of the system. Furthermore the answer includes references to the products documentation for technological topics and to the GAMP 5 guide for procedural controls that are already considered in the guide. 3.1 Life Cycle and Validation of Computerized Systems The fundamental requirement that a computerized system used as a part of GMP related activities must be validated is extended by a number of newer Annex 11 requirements detailing expectations on a systems life cycle. Requirement Reference Answer Risk management should be applied throughout the lifecycle of the computerized system. Annex 11, 1 The R&D process for Siemens software products incorporates risk management accordingly. During the validation of a customer-specific application 15 risk management should be ensured by the regulated user. Validation of a system ensures the accuracy, reliability, consistent intended performance, and the ability to discern invalid or altered records. 21 CFR (a) Yes, the development of the software product (COTS, see Annex 11, glossary) is under the control of the Siemens QMS and the Product Lifecycle Management process. The regulated user 16 should take appropriate measures to validate the customer-specific application (see Annex 11, glossary), as well as maintaining its validated state.. Validation documentation covers relevant steps of the life cycle. A process for the validation of bespoke or customized systems should be in place. Annex 11, 4.1 Annex 11, 4.6 Yes, the R&D process for the software product covers all relevant steps of the Software Development LifeCycle (SDLC). The responsibility for the validation of the customer-specific application (see Annex 11, glossary) is with the regulated user. The validation process for customer-specific applications is under the responsibility of the customer. Nonetheless Siemens is able to support the customer regarding validation activities. 15 Customer-specific application: A computerized system individually customized to suit the needs of a specific customer. 16 Regulated user: might include the roles process owner (the person responsible for the business process) as well as the system owner (the person responsible for the availability, and maintenance of a computerized system and for the security of the data residing on that system) as defined in Annex 11: Computerised Systems, European Commission / EudraLex, June 30 th SIEMENS AG

16 Requirement Reference Answer Change management and deviation management are applied during the validation process. An up-to-date inventory of all relevant systems and their GMP functionality is available. User Requirements Specifications should describe required functions, be risk-based and be traceable throughout the life-cycle. Evidence of appropriate test methods and test scenarios should be demonstrated. Annex 11, 4.2 Annex 11, 4.3 Annex 11, 4.4 Annex 11, 4.7 Yes, the R&D process for the software product includes change management, deviation management and fault corrections. The regulated user should establish appropriate change management and deviation management (see GAMP 5, appendices M8, D5). The regulated user should establish appropriate reporting, a system inventory as well as system descriptions (see GAMP 5, appendix D6). Product Requirement Specifications are used during the R&D process. The regulated user should have the User Requirement Specification appropriately considered in the systems life cycle (see GAMP 5, appendix D1). Ensuring the suitability of test methods and scenarios is an integral part of the R&D process and test planning. The regulated user should have procedural controls in place to ensure a good testing practice (see GAMP 5, appendix D5). Appropriate controls should be used over system documentation. Such controls include the distribution of, access to, and use of system operations and maintenance documentation. A formal change control procedure for system documentation maintains a time sequenced record of changes. Persons, who develop, maintain, or use electronic record/ electronic signature systems should have the education, training and experience to perform their assigned task. Computerized systems should be periodically evaluated to confirm that they remain in a valid state and are compliant with GMP. All incidents should be reported and assessed. For the availability of computerized systems supporting critical processes, provisions should be made to ensure continuity of support for those processes in the event of a system breakdown. 21 CFR (k) During the development of the product the products documentation is treated as being part of the product. Thus the documentation itself is under the control of the development process. 21 CFR (k) Annex The regulated user should establish appropriate procedural controls during development and operation of the system (see GAMP 5, appendices M9 and D6). During the development of the product changes are handled according to the development process. The regulated user should establish appropriate procedural controls during development and operation of the system (see GAMP 5, appendices M8 and O6). 21 CFR (i) Siemens processes do ensure that employees have according training for their tasks and that such training is properly documented. Annex 11, 11 Annex 11, 13 Annex 11, 16 Furthermore the COMOS academy program offers a variety of courses for users, administrators and support staff. The regulated user should establish appropriate procedural controls (see GAMP 5, appendices O3 and O8). The regulated user should establish appropriate procedural controls (see GAMP 5, appendix O5). The regulated user should appropriately consider the system in his business continuity planning (see GAMP 5, appendix O10). 16 SIEMENS AG 2013

17 Evaluation List for COMOS 3.2 Suppliers and Service Providers If the regulated user is partnering with third parties for planning, development, validation, operation and maintenance of a computerized system, then the competence and reliability of this partner should be considered utilizing a risk-based approach. Requirement Reference Answer When third parties are used, formal agreements must exist between the manufacturer and any third parties. The competency and reliability of a supplier are key factors when selecting a product or service provider. The need for an audit should be based on a risk assessment. The regulated user should ensure that the system has been developed in accordance with an appropriate Quality Management System. Documentation supplied with commercial off-the-shelf products should be reviewed by regulated users to check that user requirements are fulfilled. Quality system and audit information relating suppliers or developers of software and implemented systems should be made available to inspectors on request. Annex 11, 3.1 Annex 11, 3.2 Annex 11, 4.5 Annex 11, 4.5 Annex 11, 3.3 Annex 11, 3.4 The regulated user is responsible to establish formal agreements with suppliers and 3 rd parties. The regulated user should assess its suppliers accordingly (see GAMP 5, appendix M2). The development of COMOS follows the R&D process stipulated in Siemens Quality Management System. The regulated user is responsible for the performance of such checks and design reviews. Matter and extent of the documentation affected by this requirement should be agreed on by the regulated user and Siemens. The joint nondisclosure agreement should reflect this requirement accordingly. SIEMENS AG

18 3.3 Data Integrity The main goal of both regulations, defining criteria under which electronic records and electronic signatures are as reliable and trustworthy as paper records, requires a high degree of data integrity throughout the whole data retention period. Requirement Reference Answer The system should provide the ability to discern invalid or altered records. For records supporting batch release it should be possible to generate printouts indicating if any of the data has changed since the original entry. The system should provide the ability to generate accurate and complete copies of electronic records in both human readable and electronic form. Computerized systems exchanging data electronically with other systems should include appropriate built-in checks for the correct and secure entry and processing of data. For critical data entered manually, there should be an additional check on the accuracy of the data. Data should be secured by both physical and electronic means against damage. Regular back-ups of all relevant data should be done. 21 CFR Part (a) Annex 11, CFR (b) Annex 11, 8.1 Annex 11, 5 Annex 11, 6 Annex 11, 7.1 Annex 11, 7.2 Feasible via the following functions: time stamping and revisions for COMOS-generated documents; versioning for COMOS-external documents that are managed inside COMOS. Furthermore an audit trail can be used. Not applicable, since COMOS does not keep data supporting a batch release in its database. Yes. Accurate and complete copies can be generated in electronic portable document formats or on paper. COMOS has built in plausibility checks to validate data, which are automatically exchanged with other systems. Next to that it is possible to create individual data validation rules for each data exchange itself. Only partly applicable, since critical data entered manually in terms of Annex 11 does not represent a common use case within COMOS. Nonetheless critical operations, like design reviews and approvals, can be secured by the use of revisioning or versioning steps for documents and data, the approval of data is secured via review and approval workflows. Furthermore the system has built-in plausibility checks for data entry. The regulated user should establish appropriate security means. Furthermore the data retention period should be determined by the regulated user and appropriately considered in the users processes (see GAMP 5, appendices O3, O4, O8, O9, O11, O13) The regulated user should establish appropriate processes for backup and restore (see GAMP 5, appendix O9). Electronic records must be readily retrievable throughout the records retention period. If the sequence of system steps or events is important, then appropriate operational system checks should be enforced. 21 CFR (c) Yes. As stated above, procedural controls for Backup/Restore and Archiving/Retrieval should be established. 21 CFR (f) Yes, the sequence of activities on documents can be designed in Workflow Engineering. 18 SIEMENS AG 2013

19 Evaluation List for COMOS 3.4 Audit Trail, Change Control Support During operation regulations require to record operator actions that may result in the generation of new records or the alteration or deletion of existing records. Requirement Reference Answer The system should create a record of all GMP-relevant changes and deletions (a system generated audit trail ). For change or deletion of GMP-relevant data the reason should be documented. Management systems for data and documents should be designed to record the identity of operators entering, changing, confirming or deleting data including date and time. 21 CFR (e) Annex 11, 9 Annex 11, 12.4 Comos provides a number of features to trace changes. 1) Changes which are adapted from a working layer to the approved layer can be traced via audit trail / history monitoring. 2) 2) Changes to document can be traced via revisions / versions. The requested information is part of the revision information, version information, as well as audit trails / history monitoring. Changes to electronic records shall not obscure previously recorded information. 21 CFR (e) Supported for all revisioned documents. Furthermore a detailed tracking of changes can be realized by using cascading working layers above the approved area. The audit trail shall be retained for a period at least as long as that required for the subject electronic records. 21 CFR (e) Annex 11, 9 Yes, this is technically feasible and must be considered in the application specific backup and restore process (cp. GAMP 5, appendices O9 and O13). The audit trail should be available for review and copying by regulatory agencies. 21 CFR (e) Yes. 3.5 System Access, Identification Codes and Passwords Since access to a system must be restricted to authorized individuals and the uniqueness of electronic signatures too depends on the authenticity of user credentials, user access management is a vital set of requirements regarding the acceptance of electronic records and electronic signatures. Requirement Reference Answer System access should be limited to authorized individuals. The extent of security controls depends on the criticality of the computerized system. 21 CFR (d) 21 CFR (g) Annex 11, 12.1 Annex 11, 12.2 Yes, system access is based on the operating systems user access management system. Nonetheless also procedural controls should be established by the regulated user, as described in GAMP 5, appendix O11. System security is a key factor during design and development of the COMOS product. Nonetheless, since system security highly depends on the operating environment of each ITsystem, these aspects should be considered in security management (see GAMP 5, appendix O11). SIEMENS AG

20 Requirement Reference Answer Creation, change, and cancellation of access authorizations should be recorded. Annex 11, 12.3 Changes in the user access management are being recorded. If it is a requirement of the system that input data or instructions can only come from certain input devices (e.g. terminals) does the system check the validity of the source of any data or instructions received? (Note: This applies where data or instructions can come from more than one device, and therefore the system must verify the integrity of its source, such as a network of weigh scales, or remote, radio controlled terminals). Controls should be in place to maintain the uniqueness of each combined identification code and password, so that no individual can have the same combination of identification code and password as any other. Procedures are in place to ensure that the validity of identification codes are periodically checked. Password should periodically expire and require to be revised. A procedure should be established for recalling identification codes and passwords if a person leaves or is transferred. A procedure should be followed for electronically disabling an identification code, a password or a devices that bear or generate identification code or password information if it is lost, stolen or potentially at risk. Loss management procedures should include the issuance of temporary and permanent replacements. Devices that bear or generate identification code or password information should be initially and periodically tested to ensure proper functionality. Testing of such devices should include a check that there have been no unauthorized alterations. 21 CFR (h) Not applicable. The right to perform specific actions on data is linked to certain roles and/or individuals, not on the geographic location of an input device. Nonetheless narrowing down the possibilities to access data can be done via the distribution of licenses as well as by utilizing user rights. 21 CFR (a) Yes. The user access management of the operating systems is used as a platform for access management. Thus the combination of user-id and password are unique. 21 CFR (b) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 21 CFR (b) Yes. Password aging is based on the operating systems user access management. 21 CFR (b) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 21 CFR (c) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 21 CFR (c) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 21 CFR (e) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 21 CFR (e) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 20 SIEMENS AG 2013

21 Evaluation List for COMOS Requirement Reference Answer A loss management procedure should be followed if a device is lost or stolen. Measure for detecting attempts of unauthorized use and for informing security and management should be in place. 21 CFR (c) The regulated user should establish appropriate procedural controls (see Good Practice and Compliance for Electronic Records and Signatures, Part 2). 21 CFR (d) Yes, unsuccessful attempts to use the system or to perform electronic signatures are recognized and can be logged. The regulated user should establish appropriate procedural controls to ensure a periodic review of security and access control information logs (see GAMP 5, appendix O8). 3.6 Electronic Signature To ensure that electronic signatures are accepted as generally equivalent to handwritten signatures executed on paper, requirements are not only limited to the act of electronically signing records. They also include requirements on record keeping as well as on the manifestation of the electronic signature. Requirement Reference Answer Written policies should be established, that hold individuals accountable and responsible for actions initiated under their electronic signatures, in order to deter record and signature falsification. Signed electronic records should contain the following related Information: - The printed name of the signer - The date and time of signing - The meaning of the signing (such as approval, review, responsibility) 21 CFR (j) Annex 11, 14.a 21 CFR Annex 11, 14.c The regulated user should establish appropriate procedural controls. Yes. Referenz oder Screenshot in Kapitel 2 ratsam The above listed information is shown on displayed and printed copies of the electronic record. 21 CFR Yes. Electronic signatures shall be linked to their respective electronic records to ensure that the signatures cannot be excised, copied, or otherwise transferred to falsify an electronic record by ordinary means. Each electronic signature shall be unique to one individual and shall not be reused by, or reassigned to, anyone else. 21 CFR Annex 11, 14.b 21 CFR (a) 21 CFR (a) (2) Yes. Yes, the digital signatures used in COMOS are unique to an individual. Due to the use of unique identifiers for user accounts, the integration of document hashes in the performed electronic signature, the re-use or re-assignment of electronic signatures is effectively prevented. SIEMENS AG

22 Requirement Reference Answer When a system is used for recording certification and batch release, the system should allow only Qualified Persons to certify the release of the batches and it should clearly identify and record the person releasing or certifying the batch. Annex 11, 15 Not applicable. A COMOS system is usually not utilized for storing batch release information. Nonetheless COMOS uses digital signatures linked to an individual, and it allows strict determinations about which role and/or individual is allowed to perform a digital signature. The identity of an individual should be verified before electronic signature components are allocated. When an individual executes one or more signings not performed during a single session, each signing shall be executed using all of the electronic signature components. When an individual executes a series of signings during a single session, the first signing shall be executed using all electronic signature components; subsequent signings shall be executed using at least one private electronic signature component. The use of an individual s electronic signature by anyone other than the genuine owner would require the collaboration of two or more individuals. Electronic signatures based upon biometrics shall be designed to ensure that they cannot be used by anyone other than their genuine owner. 21 CFR (b) The regulated user should establish appropriate procedural controls for the verification of an individual s identity before allocating a user account and/or electronic signatures. 21 CFR (a) (1) (ii) 21 CFR (a) (1) (i) 21 CFR (a) (3) Yes, performing an electronic signature requires the user-id as well as the user s password. Not applicable, a shortcut for multiple signings during a continuous session is not utilized. Yes. 21 CFR (b) Not applicable, since COMOS is currently not using biometric signatures. 3.7 Open Systems The operation of an open system may require additional controls to ensure data integrity as well as the possible confidentiality of electronic records. Requirement Reference Answer To ensure the authenticity, integrity, and, as appropriate, the confidentiality of electronic records additional measures such as data encryption are used. To ensure the authenticity and integrity of electronic signatures, additional measures such as the use of digital signature standards are used. 21 CFR Not applicable. Although COMOS is designed to be operated in either an closed IT environment or one that implements additional means to make it as secure as a closed systems, critical communication paths like synchronization between WebService and WebApp are already encrypted. 21 CFR Yes, COMOS is already using digital signatures instead of electronic signatures. 22 SIEMENS AG 2013

23 Evaluation List for COMOS SIEMENS AG

24 4 References 21 CFR Part 11 Electronic Records; Electronic Signatures, US FDA, March 20th 1997 (revised as of April 1st, 2013) Volume 4 Good Manufacturing Practice Medicinal Products for Human and Veterinary Use / Annex 11: Computerised Systems, European Commission / EudraLex, June 30th 2011 ISPE; International Society of Pharmaceutical Engineers, Baseline Pharmaceutical Engineering Guides for New and Renovated Facilities, GAMP 5 A Risk-Based Approach to Compliant GxP Computerized Systems, ISPE, 2008 Basic Operation, Operating Manual, 08/2011, A5E Infrastructure planning, Operating Manual, 09/2011, A5E Maintenance, Operating Manual, 09/2011, A5E PQM, Operating Manual, 08/2011, A5E Revisions, Operating Manual, 09/2011, A5E Rights, Operating Manual, 09/2011, A5E Workflow, Operating Manual, 02/2011, A5E Disclaimer , Siemens AG The information provided in this document contains merely general descriptions or characteristics of performance which in case of actual use do not always apply as described or which may change as a result of further development of the products. An obligation to provide the respective characteristics shall only exist if expressly agreed in the terms of contract. The marks mentioned are registered trademarks of the respective owner. All product designations may be trademarks or product names of Siemens AG or supplier companies whose use by third parties for their own purposes could violate the rights of the owners. 24 SIEMENS AG 2013

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 SIEMENS AG Industry Sector VSS Pharma D-76187 Karlsruhe, Germany E-Mail: pharma@siemens.com March 2015 A5E35829023-AA

More information

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2 Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information

More information

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Datasheet Introduction US Part 11 in Title 21 of Code

More information

PTC s Windchill Product Lifecycle Management (PLM) System Facilitates Part 11 / Annex 11 Compliance

PTC s Windchill Product Lifecycle Management (PLM) System Facilitates Part 11 / Annex 11 Compliance PTC s Product Lifecycle Management (PLM) ystem Facilitates Part 11 / Annex 11 Compliance A White Paper by: Diane Gleinser, r. VP olutions and ervices, UDM Life ciences Michael Prudhomme, olution Director,

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

COMPUTERISED SYSTEMS

COMPUTERISED SYSTEMS ANNEX 11 COMPUTERISED SYSTEMS PRINCIPLE This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 08 April 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

Force.com and the FDA CFR 21 Part 11 Requirements

Force.com and the FDA CFR 21 Part 11 Requirements Force.com and the FDA CFR 21 Part 11 Requirements Overview of Capabilities to Enable Compliance Version 4, Nov 14 Last Updated: November 10, 2014 Disclaimer This statement does not confer legal advice,

More information

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008)

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) Principle The introduction of computerised systems into systems of manufacturing, including storage,

More information

Apriso and FDA 21 CFR Part 11

Apriso and FDA 21 CFR Part 11 Apriso and FDA 21 CFR Part 11 JUNE 2010 Table of Contents Executive Summary... 3 Introduction... 4 What is Compliance?... 4 Cost Effective Compliance... 4 Apriso and 21 CFR Part 11... 5 Part 11: Electronic

More information

Intland s Medical IEC & ISO Template

Intland s Medical IEC & ISO Template Intland s Medical IEC 62304 & ISO 14971 Template Intland s Medical IEC 62304 & ISO 14971 Template codebeamer ALM for Medical Device Development Intland s Medical IEC 62304 & ISO 14971 Template Medical

More information

Oracle Tech Cloud GxP Position Paper December, 2016

Oracle Tech Cloud GxP Position Paper December, 2016 Oracle Tech Cloud GxP Position Paper Page 1 of 29 Oracle Tech Cloud GxP Position Paper December, 2016 Prepared By: Subbu Viswanathan, Head of Solutions Reviewed By: David Blewitt, VP Cloud Compliance Oracle

More information

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0) Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a

More information

EU Annex 11 update. An ISPE interpretation

EU Annex 11 update. An ISPE interpretation EU Annex 11 update An ISPE interpretation ISPE Interpretation Published by Winnie Cappucci Chris Clark Tim Goossens Sion Wyn Disclaimer ISPE cannot ensure and does not warrant that computerized systems

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

COMOS Operations. Professional plant management for efficient operations.

COMOS Operations. Professional plant management for efficient operations. COMOS Operations Professional plant management for efficient operations www.siemens.com/comos COMOS From Integrated Engineering...... to Integrated Operations Integration of plant engineering and operation

More information

The Role of the LMS in 21 CFR Part 11 Compliance

The Role of the LMS in 21 CFR Part 11 Compliance The Role of the LMS in 21 CFR Part 11 Compliance Co-author: Dr. Bob McDowall, Director R.D. McDowall Limited ABSTRACT The purpose of this white paper is to describe how NetDimensions Learning addresses

More information

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND

More information

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Guidance for Industry - Computerized Systems Used in Clinical Trials

Guidance for Industry - Computerized Systems Used in Clinical Trials Page 1 of 14 Regulatory Information Computerized Systems Used in Clinical Trials Guidance for Industry - Computerized Systems Used in Clinical Trials

More information

Paperless recorders and 21 CFR part 11 compliance Videographic recorders

Paperless recorders and 21 CFR part 11 compliance Videographic recorders Sales guide SG/RandC/002 EN Paperless recorders and 21 CFR part 11 compliance Videographic recorders Introduction Today's manufacturing environment is becoming more regulated than ever and the most well

More information

Meeting future challenges for pharmaceutical plants today

Meeting future challenges for pharmaceutical plants today Siemens AG 2011 The information provided in this brochure contains merely general descriptions or characteristics of performance, which in actual case of use do not always apply as described or which may

More information

Meeting future challenges for pharmaceutical plants today

Meeting future challenges for pharmaceutical plants today Meeting future challenges for pharmaceutical plants today COMOS Software Solutions Pharmaceutical and Life Science industries siemens.com/comos Efficient engineering and management of pharmaceutical plants

More information

Electronic Records Assessment and GAMP Software Categories

Electronic Records Assessment and GAMP Software Categories Solutions for Life Science Electronic Records Assessment and GAMP Software Categories Desigo CC V3.0 - White Paper CM110803_en 2017-10-24 Version 1 siemens.com/lifescience Unrestricted Siemens Switzerland

More information

Computerised System Validation

Computerised System Validation Computerised System Validation Considerations for the Validation Lifecycle Paul Moody GMP Conference 12 th November 2014 Regulatory References EU GMP Annex 11 (2011) http://ec.europa.eu/health/files/eudralex/vol-4/annex11_01-2011_en.pdf

More information

10 "Must-Haves" for the Life Sciences Learning Management System

10 Must-Haves for the Life Sciences Learning Management System 10 "Must-Haves" for the Life Sciences Learning Management System Why the Life Sciences LMS Needs to Demonstrate Record Control UL talks to many Life Sciences companies that are exploring learning and development

More information

Introduction to 21 CFR 11 - Good Electronic Records Management

Introduction to 21 CFR 11 - Good Electronic Records Management INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL251/1 Copy Number Effective 03/04/17 Summary of Significant Changes Addition of requirements of 2016 review of Guidance by MHRA, ALCOA+, and documents related to Policy The purpose

More information

Computer System Validation Perform a Gap Analysis of your CSV Processes

Computer System Validation Perform a Gap Analysis of your CSV Processes Computer System Validation Perform a Gap Analysis of your CSV Processes Chris Wubbolt, QACV Consulting Computer and Software Validation Conference April 27, 2017 www.qacvconsulting.com 1 Objectives Computer

More information

21 CFR Part 11 Compliance

21 CFR Part 11 Compliance ENTERPRISE CONTENT MANAGEMENT ON THE MICROSOFT PLATFORM Table of Contents Page 1 Introduction Page 5-13 Electronic Record Compliance and FirstPoint Applicability Pages 14-18 Electronic Signature Compliance

More information

Atlant s atwatch CAPA TM. Corrective and Preventive Action System (CAPA) Product & Services Bundle for

Atlant s atwatch CAPA TM. Corrective and Preventive Action System (CAPA) Product & Services Bundle for Corrective and Preventive Action System (CAPA) Product & Services Bundle for Atlant s atwatch CAPA TM Atlant Systems, Inc. (781)325-8157 team@atlantsystems.com Effectively Manage CAPAs Globally According

More information

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA Implement Effective Computer System Validation Noelia Ortiz, MME, CSSGB, CQA Session Outline 1 2 3 4 5 Understanding Regulations and Guidelines Pertaining to Computer Systems Integrate SDLC and GAMP 5

More information

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0)

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0) Data Integrity Through the Life Cycle Balancing Quality and Innovation Sion Wyn Conformity +44 (0) 1492 642622 sion.wyn@conform-it.com Theme Achieving harmony Balancing quality, safety, and compliance

More information

Data Integrity Why is it important? DADM Conference - 22 August 2017

Data Integrity Why is it important? DADM Conference - 22 August 2017 Data Integrity Why is it important? DADM Conference - 22 August 2017 Maibritt Haugaard Møller, System Validation Expert Mette Ravn, Vice President, Data Management, IT and System Validation Overview of

More information

No. Question Answer IT Qualification Statement 1 SITE CONTACT

No. Question Answer IT Qualification Statement 1 SITE CONTACT SITE: Alfred Health Clinical Information System Summary of Key Questions in regards to Electronic Medical Records and Clinical Trials 1 SITE CONTACT 1.1 Name of Systems Administrator/ Security Contact/

More information

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide. Computerised Systems Wholesale Distribution Information Day, Alfred Hunt Inspector Date Insert on Master Slide Slide 1 Index What is a computerised system Updates to EU GDPs Expectations Case studies Slide

More information

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 1 How to Meet New MHRA, FDA and WHO Data Integrity Guidelines WHITE PAPER Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 2 How to

More information

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues Detecting GMP Data Integrity Issues Elaine Eborall Senior Director, GMP Compliance, Americas and Asia Pacific Compliance and External Collaboration ISPE-FDA cgmp Conference Baltimore, Maryland 2-4 June

More information

CHAPTER 5 INFORMATION TECHNOLOGY SERVICES CONTROLS

CHAPTER 5 INFORMATION TECHNOLOGY SERVICES CONTROLS 5-1 CHAPTER 5 INFORMATION TECHNOLOGY SERVICES CONTROLS INTRODUCTION In accordance with Statements on Auditing Standards Numbers 78 and 94, issued by the American Institute of Certified Public Accountants

More information

Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions)

Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions) www.arisglobal.com A White Paper Presented By ArisGlobal Compliance & Validation Validation of Software-as-a-Service (SaaS Solutions) ARIS GLOBAL CORPORATE HEADQUARTERS ArisGlobal, 1266 East Main Street,

More information

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it. 1 How to Meet New MHRA, FDA, EMA and WHO Data Integrity Guidelines white paper New Data Integrity Regulations and Practical Advice for Life Science Laboratories we prove it. 2 How to Avoid Poor Temperature

More information

Ensure Data Integrity Compliance Enterprise-Wide

Ensure Data Integrity Compliance Enterprise-Wide Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition

More information

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Computerised Systems Inspection Expectations ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Paul Moody, Inspector Slide 1 Presentation Contents Brief Introduction to the IMB Regulatory References

More information

Validation of MES and Manufacturing Automation systems

Validation of MES and Manufacturing Automation systems Validation of MES and Manufacturing Automation systems The FDA Group Presentation APRIL 26, 2017 Chinmoy Roy, B.S. (Hons.) MSCS Industry Consultant 1 Agenda What is a MES Validation concepts Validation

More information

System Requirements (URS)

System Requirements (URS) System s (URS) System Document Control System Document ID URS000XXX Version 1 DOCUMENT APPROVALS Reason For Signature Name Position Signature Date Prepared by Vic Johnson Project Manager Checked for accuracy

More information

LEGAL REQUIREMENTS and DATA INTEGRITY...

LEGAL REQUIREMENTS and DATA INTEGRITY... LEGAL REQUIREMENTS and DATA INTEGRITY... 1 1 DI Guidances MHRA GMP DI Definitions & Guidance for Industry, March 2015 Guidance on Good Data & Record Management, March, 2016 Data Integrity and Compliance

More information

Computers and E-documents in a regulated environment

Computers and E-documents in a regulated environment Computers and E-documents in a regulated environment David R Buckley FQSA info@navigategmp.com enquiries_dba@optusnet.com.au Introduction TGA 2005 name change A&NZ Pharmaceutical Products Therapeutic Goods

More information

Requisition line View New Change Cancel... 60

Requisition line View New Change Cancel... 60 User Manual erequisitions - Table of Contents How to use this manual... 4 Overview... 4 to erequisitions... 5 Overview... 5 Navigation... 6 How to access and exit erequisitions... 7 How to change password

More information

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 Copyright 2017 by British Compressed Gases Association. First printed 2017. All rights reserved. No

More information

Electronic I-9 Documentation Guardian Electronic I-9 and E-Verify Compliance with 8 CFR 274a.2

Electronic I-9 Documentation Guardian Electronic I-9 and E-Verify Compliance with 8 CFR 274a.2 Electronic I-9 Documentation Guardian Electronic I-9 and E-Verify Compliance with 8 CFR 274a.2 Abstract This document may be provided to Immigration and Customs Enforcement (ICE) in connection with a Form

More information

21CFR11 Compliance and Automated Manufacturing

21CFR11 Compliance and Automated Manufacturing Presented at the World Batch Forum North American Conference Woodcliff Lake, NJ April 7-10, 2002 107 S. Southgate Drive Chandler, Arizona 85226-3222 480-893-8803 Fax 480-893-7775 E-mail: info@wbf.org www.wbf.org

More information

TECTURA LIFE SCIENCES HIGHLIGHTS

TECTURA LIFE SCIENCES HIGHLIGHTS HIGHLIGHTS BATCH AND SERIAL NUMBER MANAGEMENT QUALITY CONTROL VENDOR RATING ELECTRONIC SIGNATURE AND AUDIT TRAIL R&D MODULE MANAGEMENT OF ACTIVE INGREDIENTS SEQUENCE PLANNING MOBILE SCANNER INTEGRATION

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

Data Integrity: Production Environment

Data Integrity: Production Environment Data Integrity: Production Environment MANUAL AND AUTOMATED SYSTEMS Ciara Turley GMP Conference 12 th November 2014 Content GMP Guide requirements and application to processing equipment Security Audit

More information

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY TO and

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY  TO and 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org 31 October 2008 Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY EMAIL TO entr-gmp@ec.europa.eu

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

User Manual. I-9 Management

User Manual. I-9 Management User Manual I-9 Management Revised April 21, 2009 This document is the user manual for a client implementing the TALX I-9 management service and is confidential to TALX Corporation. This document or any

More information

Risk Assessment is a vital component in

Risk Assessment is a vital component in This article demonstrates how the risk analysis guidance in GAMP 4 can be applied to GMPs and Good Distribution Practices (GDPs). Reprinted from The Official Journal of ISPE PHARMACEUTICAL ENGINEERING

More information

VALIDATION READY IT PROJECTS OF BEAS INDUSTRY SOLUTIONS BASED ON SAP BUSINESS ONE

VALIDATION READY IT PROJECTS OF BEAS INDUSTRY SOLUTIONS BASED ON SAP BUSINESS ONE White Paper VALIDATION READY IT PROJECTS OF BEAS INDUSTRY SOLUTIONS BASED ON SAP BUSINESS ONE The comprehensive Solution for small and mid-sized Manufacturing Enterprises in regulated Industries CONTENT

More information

GAMP5 Validation for Dynamics 365

GAMP5 Validation for Dynamics 365 GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning

More information

Regulatory Expectations, Standards & Guidelines

Regulatory Expectations, Standards & Guidelines Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory

More information

Security overview. 2. Physical security

Security overview. 2. Physical security 1. Collaborate on your projects in a secure environment Thousands of businesses, including Fortune 500 corporations, trust Wrike for managing their projects through collaboration in the cloud. Security

More information

GAMP Guideline & Validation Documentation

GAMP Guideline & Validation Documentation GAMP Guideline & Validation Documentation Danilo Maruccia Milano, 21 Marzo 2006 GAMP Guideline & Validation Documentation GAMP Guideline Planning documents Specification Documents Testing Documents Acceptance

More information

COMPUTERIZED SYSTEM VALIDATION

COMPUTERIZED SYSTEM VALIDATION www.kevintech.com Current Practices of COMPUTERIZED SYSTEM VALIDATION Kevin ISSUE.1/2017 CONNECT INSIDE - Basics of Computerized System Validation - Life Cycle of Computerized System The less manual the

More information

PLA Product Overview. PLA 2.1 Overview

PLA Product Overview. PLA 2.1 Overview PLA 2.1 - Software For Biological Assays Product Overview PLA 2.1 Overview PARALLEL-LINE AND PARALLEL-LOGISTIC ASSAYS Parallel-Logistic Assay Biological or potency assays are frequently analyzed with the

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

FUNCTIONS CRYOGENIC-GASES TERMINAL AUTOMATION SYSTEM FUNCTION OVERVIEW DESCRIPTION. Graphical User Interface (GUI)

FUNCTIONS CRYOGENIC-GASES TERMINAL AUTOMATION SYSTEM FUNCTION OVERVIEW DESCRIPTION. Graphical User Interface (GUI) FUNCTIONS CRYOGENIC-GASES TERMINAL AUTOMATION SYSTEM DESCRIPTION CRYO.TAS is a freely scalable terminal automation system. It can be purchased as a turn-key overall system with our standard hardware, or

More information

Beamex CMX Calibration Software and GAMP - Good Automated Manufacturing Practices

Beamex CMX Calibration Software and GAMP - Good Automated Manufacturing Practices Beamex CMX Calibration Software and GAMP - Good Automated Manufacturing Practices GAMP Good Automated Manufacturing Practices The GAMP Forum was established in 1991 to help promote the understanding of

More information

U.S. FDA TiTle 21 CFR PART 11 ComPliAnCe ASSeSSmenT of SAP ReCiPe management

U.S. FDA TiTle 21 CFR PART 11 ComPliAnCe ASSeSSmenT of SAP ReCiPe management U.S. FDA Title 21 CFR Part 11 Compliance Assessment of SAP Recipe Management Copyright 2007 SAP AG. All rights reserved. No part of this publication may be reproduced or transmitted in any form or for

More information

Mobile for Android User Guide

Mobile for Android User Guide Version 1.7 Copyright 2013, 2017, Oracle and/or its affiliates. All rights reserved. This software and related documentation are provided under a license agreement containing restrictions on use and disclosure

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

U.S. FDA TiTle 21 CFR PART 11 ComPliAnCe ASSeSSmenT of SAP SRm

U.S. FDA TiTle 21 CFR PART 11 ComPliAnCe ASSeSSmenT of SAP SRm U.S. FDA Title 21 CFR Part 11 Compliance Assessment of SAP SRM Disclaimer These materials are subject to change without notice. SAP AG s compliance analysis with respect to SAP software performance based

More information

QM-Documentation with roxtra Document Creation Document Editing Workflow Management Distribution and Approval...

QM-Documentation with roxtra Document Creation Document Editing Workflow Management Distribution and Approval... Product Highlights Contents QM-Documentation with roxtra... 3 Document Creation... 4 Document Editing... 5 Workflow Management... 6 Distribution and Approval... 7 Search & Find... 8 Version Control and

More information

LIMS FOR TESTING LABORATORIES AN OVERVIEW OF FEATURES AND COMPLIANCE FOR TESTING LABORATORIES

LIMS FOR TESTING LABORATORIES AN OVERVIEW OF FEATURES AND COMPLIANCE FOR TESTING LABORATORIES WHITE PAPER LIMS FOR TESTING LABORATORIES AN OVERVIEW OF FEATURES AND COMPLIANCE FOR TESTING LABORATORIES 427 N Tatnall St #42818 Wilmington DE 19801-2230 USA A laboratory that performs any type of test

More information

Electronic Records and Electronic Signatures (21 CFR Part 11)

Electronic Records and Electronic Signatures (21 CFR Part 11) Training Course Computerized System Validation in the Pharmaceutical Industry Istanbul, 16-17 January 2003 Electronic Records and Electronic Signatures (21 CFR Part 11) Hans-Beat Jenny, SwissMedic, Basel

More information

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (08) 69 R7 VALIDATION OF COMPUTERISED SYSTEMS CORE DOCUMENT Full document title and reference Document type Validation of Computerised

More information

ScreenMaster RVG200 Paperless recorder

ScreenMaster RVG200 Paperless recorder Technical description TD/RandC/016 EN ScreenMaster RVG200 Paperless recorder RVG200 and AMS2750 in the heat treatment industry Measurement made easy Introduction AMS2750 (Aerospace Material Specification)

More information

Corrective and Preventive Action System (CAPA) Product & Services Bundle for Winchester s adwatch CAPA TM. Life Sciences Companies

Corrective and Preventive Action System (CAPA) Product & Services Bundle for Winchester s adwatch CAPA TM. Life Sciences Companies Life Sciences Companies Corrective and Preventive Action System (CAPA) Product & Services Bundle for Winchester s adwatch CAPA TM Effectively Manage CAPAs Globally According to regulations, all companies

More information

Water purification in the pharmaceutical industry

Water purification in the pharmaceutical industry ABB MEASUREMENT & ANALYTICS APPLICATION DESCRIPTION Water purification in the pharmaceutical industry Providing independent verification and validation of the water purification process for compliance

More information

GCP Basics - refresher

GCP Basics - refresher p. 01 GCP Basics - refresher Agenda: p. 02 Brief History of GCP GCP Regulations Principles of ICH E6 Sponsor Responsibilities Computer Systems Common Compliance Issues Brief History of GCP 3 Brief History

More information

PAI Inspections, Observations and Data Integrity

PAI Inspections, Observations and Data Integrity PAI Inspections, Observations and Data Integrity Krishna Ghosh, Ph.D. Office of Pharmaceutical Quality Office of Process and Facilities Center for Drug Evaluation and Research November, 2017 20 November

More information

Deltek Touch Time & Expense for Vision. User Guide

Deltek Touch Time & Expense for Vision. User Guide Deltek Touch Time & Expense for Vision User Guide September 2017 While Deltek has attempted to verify that the information in this document is accurate and complete, some typographical or technical errors

More information

Government-wide: Controls Over Disposal of IT Assets

Government-wide: Controls Over Disposal of IT Assets Performance Audits 2 Government-wide: Controls Over Disposal of IT Assets Summary Government does not have adequate data security and inventory controls to prevent sensitive information from being exposed

More information

IBM Clinical Development

IBM Clinical Development Service Description IBM Clinical Development This Service Description describes the Cloud Service IBM provides to Client. Client means the contracting party and its authorized users and recipients of the

More information

The Leading Solution for Method Validation VALIDAT

The Leading Solution for Method Validation VALIDAT The Leading Solution for Method Validation 01 Our Competence for Your Work 02 Overview 02 03 04 05 06 07 Better Overview, Less Costs Page 03 Secure Solution in Certified Quality Page 04 Increased Efficiency

More information

Policy Outsourcing and Cloud-Based File Sharing

Policy Outsourcing and Cloud-Based File Sharing Policy Outsourcing and Cloud-Based File Sharing Version 3.3 Table of Contents Outsourcing and Cloud-Based File Sharing Policy... 2 Outsourcing Cloud-Based File Sharing Management Standard... 2 Overview...

More information

Welcome to the course on the initial configuration process of the Intercompany Integration solution.

Welcome to the course on the initial configuration process of the Intercompany Integration solution. Welcome to the course on the initial configuration process of the Intercompany Integration solution. In this course, you will see how to: Follow the process of initializing the branch, head office and

More information

SIMATIC PCS 7 Process Control System New Perspectives for Increased Productivity 2005 Highlights. simatic PCS7

SIMATIC PCS 7 Process Control System New Perspectives for Increased Productivity 2005 Highlights. simatic PCS7 SIMATIC PCS 7 Process Control System New Perspectives for Increased Productivity 2005 Highlights simatic PCS7 PROCESS FIELD BUS Performance, Flexibility, Scalability, Security. Ready for new challenges.

More information

Lifecycle Management for SAP BusinessObjects User Guide

Lifecycle Management for SAP BusinessObjects User Guide Lifecycle Management for SAP BusinessObjects User Guide SAP BusinessObjects XI 3.1 Sevice Pack 3 windows Copyright 2010 SAP AG. All rights reserved.sap, R/3, SAP NetWeaver, Duet, PartnerEdge, ByDesign,

More information

Fibonacci Sequences Improve GAMP 5 Risk Assessment for GLP Computerized Systems

Fibonacci Sequences Improve GAMP 5 Risk Assessment for GLP Computerized Systems WHITE PAPER Analyst Software Validation Service Fibonacci Sequences Improve GAMP 5 Risk Assessment for GLP Computerized Systems S. D. Nelson, Blair James, Patrick Quinn-Paquet, Justyna Sekula, Dave Abramowitz

More information

PLA 2.0. Software for Analyzing Parallel-Line and Parallel-Logistics Assays

PLA 2.0. Software for Analyzing Parallel-Line and Parallel-Logistics Assays PLA 2.0 Software for Analyzing Parallel-Line and Parallel-Logistics Assays Parallel-Line and Parallel-Logistics Assays Biological or potency assays are frequently analyzed with the help of the parallel-line

More information

Good Laboratory Practice. Good Laboratory Practice. What is behind all this?

Good Laboratory Practice. Good Laboratory Practice. What is behind all this? Good Laboratory Practice What is behind all this? 1 Summary The effects of the thalidomide scandal are still felt, which is why the next generation will probably also be aware of it. And the victims not

More information

Dovico Planning & Timesheet v4 BEST PRACTICES

Dovico Planning & Timesheet v4 BEST PRACTICES Dovico Planning & Timesheet v4 Dovico Planning & Timesheet v4 Audience and Context This document is intended to help clients plan the configuration and use of Dovico Planning & Timesheet. It is to be used

More information

A Comprehensive Approach to Find and Remediate Data Integrity Problems

A Comprehensive Approach to Find and Remediate Data Integrity Problems A Comprehensive Approach to Find and Remediate Data Integrity Problems June 14, 2017 Copyright 2017 QuintilesIMS. All rights reserved. What is data integrity? Whom does it apply to? Definitions matter

More information

Infor EAM for Life Sciences

Infor EAM for Life Sciences Infor EAM Infor EAM for Life Sciences Protect your bottom line The stringent regulations imposed on life sciences companies are in place for a good reason to reduce the health, safety, and security risks

More information

REXS. Risk Expert System

REXS. Risk Expert System REXS Risk Expert System REXS by experts for experts REXS is based on the extensive experience of VTU experts in the GMP and safety sector. The system is specifically designed to support experts engaged

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

SIMATIC BATCH. Automation of batch processes with SIMATIC BATCH

SIMATIC BATCH. Automation of batch processes with SIMATIC BATCH Automation of batch processes with clients and OS clients Engineering System OS-LAN Batch server OS server Plant bus SIMATIC PCS 7 always offers the right solution for attractively priced and effective

More information